Covered recipient · General Payments record
SARAH M FAJGENBAUM TESLJA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$1,309.98
- Reported across 86 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $162.36 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $99.17 | 6 |
| Neurocrine BioSciences, Inc. | $30.10 | 1 |
| Lundbeck LLC | $16.76 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $16.87 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078106454 | CMS |
| Janssen Pharmaceuticals, Inc | $16.91 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078105252 | CMS |
| Janssen Pharmaceuticals, Inc | $16.88 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078105150 | CMS |
| Janssen Pharmaceuticals, Inc | $14.71 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078105440 | CMS |
| Janssen Pharmaceuticals, Inc | $17.69 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078106680 | CMS |
| Janssen Pharmaceuticals, Inc | $16.11 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078106152 | CMS |
| Lundbeck LLC | $16.76 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145914427 | CMS |
| Neurocrine Biosciences, Inc. | $30.10 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150825744 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.33 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118890706 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.